PlainRecalls
FDA Drug Low Class III Terminated

LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5

Reported: July 21, 2021 Initiated: June 23, 2021 #D-0655-2021

Product Description

LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5

Reason for Recall

FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.

Details

Recalling Firm
Partner Therapeutics Inc
Units Affected
32,260 vials
Distribution
Product was distributed to one government account (ASPR)
Location
Lynnwood, WA

Frequently Asked Questions

What product was recalled?
LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5. Recalled by Partner Therapeutics Inc. Units affected: 32,260 vials.
Why was this product recalled?
FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 21, 2021. Severity: Low. Recall number: D-0655-2021.